In patients with trapeziometacarpal arthrosis, we tested the hypothesis that there is no difference in arm-specific disability 5-15 weeks after prescription of a pre-fabricated neoprene or a custom-made thermoplast hand-based thumb spica splint with the metacarpophalangeal joint included and the first interphalangeal joint free.
Introduction
A hand-based thumb spica splint with the interphalangeal (IP) joint free is a specific nonoperative palliative treatment for trapeziometacarpal (TMC) arthrosis. The goals of splint wear are improved comfort and function [1] [2] [3] [4] . The data regarding specific splint materials are limited, but suggest that shorter more flexible splints are preferred by patients and equally effective 4, 5 .
This randomized prospective clinical trial of patients with a diagnosis of TMC arthrosis tested the null hypothesis that there is no difference in arm-specific disability 5-15 weeks after prescription of a pre-fabricated neoprene hand-based thumb spica splint with the metacarpophalangeal (MP) included and the IP joint free or a similar custom-made thumb spica splint from thermoplast. Secondary study questions addressed the null hypotheses that there are no statistically significant differences between a neoprene and thermoplast splint regarding improvement of disability, pain at follow-up and satisfaction with the splint; that arm-specific disability does not correlate with higher scores on instruments assessing psychological factors; and that no factors associate with higher arm-specific disability, pain and satisfaction. We also examined the percentage of patients that had surgery within the study period.
Method
The Human Research Committee at our institution in the United States approved this prospective, single center, unblinded, equally randomized [1:1] controlled parallel-group clinical trial comparing hand-based thumb spica splints of pre-fabricated neoprene with custom-made thermoplast for patients with TMC arthrosis.
From January 2006 through December 2011, English-speaking adult patients that requested a splint for TMC arthrosis were enrolled from the outpatient office of two hand surgeons at one tertiary care hospital. Patients were considered eligible for this trial if they were 18 years or older and clinically diagnosed with TMC arthrosis by the hand surgeon. Additional radiological assessment was not considered necessary for the diagnosis. Patients were not eligible if they had a history of surgically treated TMC arthrosis.
Randomization
The allocation was concealed from the independent research assistant until informed consent was obtained. After informed consent was obtained, patients were randomly assigned to either a neoprene or a thermoplast splint, according to a computer generated sequence of random numbers (Windows Excel; Microsoft, Redmond, WA). Splint assignment was not blinded to any of the involved parties.
Intervention
According to the randomization, a trained occupational therapist provided either a pre-fabricated neoprene Comfort Cool® Thumb CMC Restriction Splint (North Coast Medical, Gilroy, CA) or a customized 3.2 mm thick thermoplast hand-based thumb spica splint with the MP included, and the IP joint and wrist free. Patients were told to wear the splint as needed for pain relief with daily activities and even at night if it helped them sleep. This was a pragmatic clinical trial, and consistent with usual practice, patients were not prohibited from using other treatments including other splints. Patients were allowed to have their splint adjusted.
Evaluation
An independent research assistant not involved in patient care evaluated patients at both time points.
At time of enrollment, each patient completed the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire 6 , the Pain Anxiety Symptoms Scale (PASS) 7 , the Pain Catastrophizing Scale (PCS) 8 , the Center for Epidemiological Studies -Depression scale (CES-D) 9,10 and the Whiteley Index 11 . In addition, pinch and grip strength were recorded, and pain was measured on an ordinal scale from 0 (no pain) to 10 (worst pain you ever had). Pain improvement was calculated by deducting the follow-up pain score from the initial pain score.
Patients were asked to return 5-15 weeks later to complete the DASH questionnaire, ordinal scales for pain and satisfaction with the splint, and grip and pinch strength. The six 11-point ordinal satisfaction scales asked for (1) satisfaction with the splint, (2) how the splint helped in terms of pain relief, (3) how the splint helped in keeping active, doing daily living activities, (4) if the splint improved quality of life, (5) how comfortable wearing the splint was, and (6) how easy it was to follow the hand therapist instructions regarding splint use. A higher score indicates greater satisfaction or help. If patients did not return within the approved window between 5 and 15 weeks after enrollment, an independent research assistant tried to contact them by phone, a maximum of three times, to schedule a research appointment.
Both grip and pinch strength were measured as the average of three attempts. Grip strength was measured using the Jamar dynamometer (Asimov Engineering, Los Angeles, California) with the hand grip placed at the second or third station depending on the hand size. During the grip strength testing, the arm was at the side, the elbow at 90° flexion, and the forearm and wrist in neutral position. Key pinch strength was recorded using the B&L pinch gauge (B&L Engineering, Santa Ana, California) with the thumb pad on the pinch gauge and the lateral aspect of the middle phalanx of the index finger underneath. Both grip and pinch strength of the affected hand were compared with the opposite or least involved (in case of bilateral involvement) side. Whenever grip and pinch strength are mentioned, these refer to the percentage of strength calculation (involved/noninvolved hand).
Outcome measures
This study was designed with a single primary study question with a single primary endpoint. All other analyses should be considered secondary and hypothesis-generating. The primary endpoint was the DASH score at 5-15 weeks follow-up. Secondary endpoints were DASH score at enrollment, improvement in DASH score, pain intensity at both time points, improvement in pain intensity, grip and pinch strength at both time points, and satisfaction at follow-up. The remaining variables were all considered to be explanatory variables. Study participation was considered complete if the DASH questionnaire was completed at both time points.
Sample size analysis
An a-priori sample size analysis using a two-tailed Student's t test estimated the need to evaluate 60 participants to detect a clinically relevant difference of 10 points in followup DASH scores between the two prospective cohorts at 90% power, and a significance level of 0.05. When we were close to our target enrollment number of 60 subjects, approximately half of the study population had not returned for the 5-15 weeks evaluation. Therefore, the target was raised to 120 patients.
Statistical analysis
Analysis was by intention-to-treat, meaning that patients were analyzed based on the type of splint assignment irrespective of what splint they actually received from the occupational therapist. In other words, this was a pragmatic trial 12, 13 comparing the effectiveness (the effect of prescribing a certain type of splint in actual practice where patients do not follow prescriptions precisely) rather than the efficacy (how the splints work under ideal conditions) of each splint.
Continuous variables are reported with means, standard deviations, and ranges. The data was not normally distributed according to the Kolmogorov-Smirnov test and therefore non-parametric tests were done to determine the relationship between two variables. The Mann-Whitney U test was conducted to evaluate the difference in mean between two groups. The Kruskal-Wallis test was used to assess the difference in mean between more than two groups. The relationship between categorical variables was evaluated with use of the Pearson Chi-Square test. Spearman correlations were used to assess the relationship between continuous variables. The difference between items measured at both time points (e.g., DASH questionnaire) were evaluated with the Wilcoxon Signed-Rank test.
Any DASH questionnaires with 4 and 5 missing items (5 at enrollment and 1 at followup) were analyzed. In case of missing items on a questionnaire, the score was scaled based on the number of items completed by the patient, taking into account any reverse scored items. The adjusted total scores were rounded to the nearest integer. This method was used for the following questionnaires (not more than 21% of items were missing per patient): PASS, PCS, CES-D and Whiteley Index. Only for data of the patients that completed study participation, a few missing data points were imputed with the mean cohort score for the specific questionnaire or scale. One or more missing values of patients that did not complete the study were excluded from an analysis if it required the missing data.
The SPSS software program, version 15.0, was used for all statistical analyses and a two-sided P value <0.05 was considered statistically significant.
Results

Participant flow
An overview of the participant flow is shown in Fig. 1 . Three patients completed the study at 27, 29 and 65 weeks after enrollment respectively because they missed their original scheduled appointment and returned late. Sixty-two patients (52%) completed the study an average of 9 ± 9 weeks (range, 4-65 weeks) after enrollment: 32 patients (54%) in the neoprene cohort and 30 patients (56%) in the thermoplast cohort. These 62 patients that completed the study were, on average, about 6 years older than 51 patients that did not return (P < 0.00044) ( Table 1) .
Numbers analyzed
All following mentioned missing data points were imputed with the mean cohort score for the specific questionnaire or scale. At enrollment, the pain scale, CES-D questionnaire and Whiteley Index were completed by 61 of 62 patients in total. Grip and pinch strength were measured in 59 patients. At follow-up, pain, help from the splint in terms pain of relief, help from the splint in keeping active and doing daily activities, and improvement of quality of life were rated by 61 patients. Satisfaction with the splint and comfort of the splint were rated by 60 patients. The ease of following the hand therapist instructions regarding splint use was rated by 59 patients. Pain improvement could not be calculated for two patients, and grip and pinch strength was measured in 61 patients because one patient could not return to the clinic but did want to complete the study so instead the follow-up survey was completed over the phone.
Baseline characteristics of cohorts
An overview of the two cohorts' baseline characteristics is given in Table 2 .
Follow-up comparison of cohorts
The only significant difference between the two splints was comfort (5.3 vs 6.8 points, P = 0.048), in favor of patients that were assigned to a neoprene splint ( Table 2) . The numbers in bold indicate significant P values (P < 0.05). NS = not significant. 
Predictors of initial DASH score
In bivariable analysis, there was a significant association between the initial DASH score and sex (r = 0.26, P = 0.042), the PCS score (r = 0.27, P = 0.035) and the CES-D score (r = 0.33, P = 0.0081) ( Table 3) .
Predictors of follow-up DASH score
The average DASH score did not decrease significantly from a mean of 28 ± 17 points (range, 2.5-72) at enrollment to a mean of 25 ± 15 points (range, 3.3-63) at follow-up (P = 0.21). In bivariable analysis, the follow-up DASH score correlated significantly with the CES-D score (r = 0.30, P = 0.019) and the Whiteley Index score (r = 0.33, P = 0.0098) ( Table 4 ). 
Predictors of follow-up pain rating
The average pain decreased significantly from a mean of 5.0 ± 2.2 points (range, 1-10) at enrollment to a mean of 4.2 ± 2.1 points (range, 0-9) at follow-up (P = 0.048). Pain improved 0.9 ± 2.6 points on average (range, 4 points less to 7 points greater pain). In bivariable analysis, there was a significant correlation between follow-up pain rating and education (r = −0.30, P = 0.017), the PCS score (r = 0.30, P = 0.018) and the CES-D score (r = 0.30, P = 0.018) ( Table 5 ).
Predictors of satisfaction
Overall satisfaction with the splint, regardless of what type, averaged 6.3 ± 2.8 points (range, 0-10). Higher rated help from the splint in keeping active and doing daily activities was significantly associated with women (r = 0.26, P = 0.037). There were small but significant associations between satisfaction with therapist instructions and fewer symptoms of depression (r = −0.27, P = 0.035), less catastrophic thinking (r = −0.29, P = 0.022), and less heightened illness concern (r = −0.33, P = 0.0099) ( Table 6 ). Pinch strength (%) −0.37 0.0032
The numbers in bold indicate significant P values (P < 0.05). NS = not significant.
Grip and pinch strength
Grip strength improved slightly, but significantly from a mean of 80 ± 25% (range, 17-148) of the opposite side at enrollment to a mean of 88 ± 27% (range, 42-217) at follow-up (P = 0.010). Pinch strength improved slightly, but significantly from a mean of 84 ± 21% (range, 26-161) at enrollment to a mean of 91 ± 19% (range, 41-133) at follow-up (P = 0.015). The numbers in bold indicate significant P values (P < 0.05). NS = not significant.
Operative treatment
Only 10 of 113 patients (9%)-including seven that completed the protocol and three that did not-elected operative treatment to date (at an average follow-up of 3.9 years) at one of the nine major regional hospitals that share our electronic medical record, eight in the practice of the same surgeon that prescribed the study splint, and two in the practice of another surgeon. Surgeon A operated on five patients (22%), and surgeon B, who was less likely to operate overall and had the two patients leave his practice to get surgery somewhere else, operated on three patients (3.3%). The numbers in bold indicate significant P values (P < 0.05). NS = not significant. The numbers in bold indicate significant P values (P < 0.05). NS = not significant.
Discussion
Our primary null hypothesis that there would be no difference between arm-specific disability at follow-up was not rejected in this sample. The neoprene splint was on average more comfortable, but otherwise comparable to the thermoplast splint in our sample. This was a superiority trial, so we cannot conclude that the splints are equivalent, only that this trial did not show evidence of a clinically meaningful advantage for one splint over the other. Average pain, grip and pinch strength all improved significantly with either splint, but the average arm-specific disability (DASH) did not change. Most patients either did not return or continued nonoperative treatment, so at a minimum, splints provide patients time to reflect on their disease and adjust to it. The strengths of this study were that the design was a prospective randomized trial with adequate power for detecting a clinically relevant difference in DASH score; that the splints were only different in terms of material; and that a research assistant, not involved in patient care, took the measurements.
This study was designed and powered for a single primary study question addressing disability 5-15 weeks after splint prescription. With the caveat that we were only interested in substantial differences in DASH score, we were not able to reject our null hypothesis, but the confidence interval was wide (95% CI, −7.4 to 7.7), so it is possible that differences smaller than 10 points on the DASH might be detected in a larger trial. All of the secondary study questions-including the difference in patient preferences-should be considered hypothesis-generating. Additional limitations of this study were the use of DASH scores with up to five missing answers instead of the validated three missing items; the reliance on clinical rather than a radiological diagnosis of TMC arthrosis which did not account for the degree of objective pathophysiology; the length of follow-up which might be specific to our practice; the research assistant who evaluated patients at both time points was not blinded to the randomization; the use of follow-up data from three patients who completed the protocol later than the accepted time-frame; and the large number of patients that did not complete the study. Satisfied patients may not have felt the need to return, which could explain the high loss to follow-up (43%) and the relatively low recorded satisfaction; however, the opposite may also be true. This study was conducted at a tertiary care hospital which might affect the generalizability of this study, although the majority of our patients come directly from primary care doctors in our network and did not receive any previous treatment. The results should be interpreted in light of the fact that these represent the average patient.
Partially consistent with our results, a review in 2007 concluded that there was no superior splint in terms of comfort, pain relief or function 14 . In 2004 and 2011, two crossover trials compared a custom-made thumb spica thermoplastic splint with the MP joint free to a pre-fabricated short neoprene splint with the MP included, and found that patients preferred the neoprene over the thermoplast splint 4, 5 .
Splints significantly, but modestly, decrease pain for TMC arthrosis in this and prior studies 3, 4, 15 . Weiss et al. 4 found that the neoprene splint provided greater pain relief than the thermoplast splint, while Sillem et al. 5 found the opposite. In 2011, no between-group difference in the effect on subjective and objective hand function was found by Sillem et al.; although only the thermoplastic splint significantly improved subjective hand function 5 .
Disability with TMC arthrosis after splinting related more to depression and heightened illness concern than demographics or treatment details, but most of the variation in disability remains unexplained. That depressive symptoms correlated with disability is consistent with earlier research 16, 17 .
Berggren et al. 18 studied 33 patients seeking TMC arthroplasty that were sent to an occupational therapist and randomized to one of three treatment strategies: one group treated with adaptive accessories (e.g., pen handle, book support, and bread saw) and the other two groups treated with one of two splint types in addition to treatment with the accessories. During a seven month follow-up only 30% had surgery, and after 7 years, during which time four patients died, only two more patients requested operative treatment.
Based on the current study, and in the context of other data, we would advise patients as follows: (1) a pre-fabricated, soft splint provides more comfort with less cost than a custom-made firm splint; (2) the substantial variation in symptoms and disability remains incompletely explained, but optimal mood and effective adaptive strategies are important opportunities for less pain and better function; and (3) a small percentage of patients that seek attention for TMC arthrosis request operative treatment within the first 4 years or so of their first visit with a hand surgeon and after splint treatment. The finding of minimal difference between splints on average (neoprene slightly more comfortable and otherwise no differences) suggests that surgeons and therapists can spend less time discussing the technical aspects of various splint options and more time coaching patients on other adaptive and palliative measures to help patients manage their symptoms and remain as functional as possible.
